About RetInSight
RetInSight is a company based in Vienna (Austria) founded in 2020 by Amir Sadeghipour, Hans Peter Schwarz, and Corinna Zur Bonsen-Thomas was acquired by Topconhealthcare in May 2025. RetInSight offers products and services including GA Monitor and Fluid Monitor. RetInSight operates in a competitive market with competitors including Mediwhale, Abyss Processing, BioScan AI, Deekh AI and NewVision Fundus, among others.
- Headquarter Vienna, Austria
- Founders Amir Sadeghipour, Hans Peter Schwarz, Corinna Zur Bonsen-Thomas
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Retinsight Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.23 M (USD), Grant
Jan 01, 2024
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Topconhealthcare
(May 05, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RetInSight
RetInSight offers a comprehensive portfolio of products and services, including GA Monitor and Fluid Monitor.
AI tool for assessing Geographic Atrophy in retinal diseases
AI for quantifying fluids in eye disease treatment
Funding Insights of RetInSight
Investors in RetInSight
RetInSight has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Topconhealthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Offers medical devices and software for ophthalmic diagnostics and patient care.
|
Locked | Locked | Locked |
Investor details for RetInSight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RetInSight
Investment portfolio details for RetInSight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RetInSight
Detailed financials for RetInSight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Retinsight Comparisons
Peer comparison for RetInSight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RetInSight
RetInSight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mediwhale, Abyss Processing, BioScan AI, Deekh AI and NewVision Fundus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Retinal images are analyzed by AI for chronic disease biomarkers.
|
|
| Locked | Locked | Locked |
Delivers AI-based 3D image diagnosis for glaucoma detection by professionals.
|
|
| Locked | Locked | Locked |
AI-powered solutions for early detection of diseases using hardware and software.
|
|
| Locked | Locked | Locked |
Offers AI-based solutions for ophthalmology diagnostics and services.
|
|
| Locked | Locked | Locked |
Software for enhancing and storing medical images in ophthalmology field.
|
Detailed competitors of RetInSight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Retinsight
Complete news archive for RetInSight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RetInSight
RetInSight was founded in 2020 and raised its 1st funding round 4 years after it was founded.
RetInSight is headquartered in Vienna, Austria.
Corinna Zur Bonsen-Thomas is the current CEO of RetInSight. They have also founded this company.
RetInSight was established in 2020 in Vienna, Austria, within the healthcare technology sector. An AI-driven platform has been created for diagnosing eye diseases, focusing on intraretinal and subretinal fluid localization and quantification. These solutions support diagnosis, prognosis, and therapy guidance. Deep learning is employed to connect a mobile app with PACSEMR systems and imaging devices, enabling integrated operations.
RetInSight's top competitors include Mediwhale, Deekh AI and Abyss Processing.
RetInSight offers GA Monitor and Fluid Monitor.
RetInSight has 2 investors. Key investors include European Union, and Topconhealthcare.